Peptide Sequencing, Peptide Mapping and NMR in Sameness Studies: Why Orthogonal Methods Matter
Introduction: Peptide Sequencing and Mapping for Sameness Study is the foundation for demonstrating structural identity between a generic peptide drug […]
Regulatory Requirements for Peptide Sameness Study (FDA & Health Canada)
Introduction: FDA Peptide Sameness Study Requirements define the scientific and regulatory framework needed to demonstrate that a generic synthetic peptide
Regulatory Requirements for Peptide Sameness Study (FDA & Health Canada) Read More »
Nitrosamine Testing in Controlled Substances and Highly Potent APIs (HPAPIs)
Introduction: Why Nitrosamine Testing Highly Potent APIs Requires Specialized Expertise Nitrosamine Testing Highly Potent APIs demands highly sensitive analytical methods,
Nitrosamine Testing in Controlled Substances and Highly Potent APIs (HPAPIs) Read More »
Case Study: Reformulation Strategy to Eliminate Nitrosamine Risk Without Changing Bioequivalence
Introduction: Applying a Nitrosamine Reformulation Strategy Without Compromising Bioequivalence A structured Nitrosamine Reformulation Strategy can block nitrosamine formation pathways while
Peptide Sameness Study vs Biosimilar Comparability: What’s the Difference?
Introduction: Peptide Sameness vs Biosimilar Comparability is one of the most misunderstood concepts in modern pharmaceutical development. While both involve
Peptide Sameness Study vs Biosimilar Comparability: What’s the Difference? Read More »
Case Study: Root Cause Investigation of Unexpected NDMA Spike in Finished Product
Introduction In this NDMA Root Cause Investigation Case Study, we examine a real-world scenario involving an unexpected spike of N-nitrosodimethylamine
Case Study: Root Cause Investigation of Unexpected NDMA Spike in Finished Product Read More »
Selecting the Right Nitrosamine Testing CRO: A Technical Due Diligence Checklist
Introduction Nitrosamine Testing CRO Selection requires detailed scientific evaluation and regulatory awareness. Global authorities continue to update nitrosamine guidance, and
Selecting the Right Nitrosamine Testing CRO: A Technical Due Diligence Checklist Read More »
Case Study: Sameness Evaluation of Semaglutide Generic project submission to Health Canada
Introduction: Semaglutide Sameness Evaluation for Health Canada is a scientifically rigorous analytical process required to demonstrate that a generic semaglutide
Analytical Testing Services for Peptide-Oligonucleotide Conjugates
Introduction: Why Specialized Peptide Oligonucleotide Conjugate Analysis Is Essential Peptide Oligonucleotide Conjugate Analysis is critical because peptide–oligonucleotide conjugates (POCs) combine
Analytical Testing Services for Peptide-Oligonucleotide Conjugates Read More »
NDA vs ANDA Nitrosamine Data Requirements: What Sponsors Must Submit
Introduction: The global pharmaceutical industry is facing strict regulatory control for mutagenic impurities, especially nitrosamines. A strong understanding of NDA
NDA vs ANDA Nitrosamine Data Requirements: What Sponsors Must Submit Read More »